{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:41:27Z","timestamp":1788280887797,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA292893"],"award-info":[{"award-number":["R01 CA292893"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA279595"],"award-info":[{"award-number":["R01 CA279595"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-026-01184-5","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:02:42Z","timestamp":1782464562000},"page":"944-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics"],"prefix":"10.1038","volume":"7","author":[{"given":"Xin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-1032","authenticated-orcid":false,"given":"Song-Bai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve E.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5464-0861","authenticated-orcid":false,"given":"Le Xuan Truong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-4336","authenticated-orcid":false,"given":"Jinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunsong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Prasad","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5040-4156","authenticated-orcid":false,"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-0088","authenticated-orcid":false,"given":"Lianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-0235","authenticated-orcid":false,"given":"Zhenhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-2902","authenticated-orcid":false,"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8737-6830","authenticated-orcid":false,"given":"Chun-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7230-0307","authenticated-orcid":false,"given":"Stefano","family":"Tiziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-5262","authenticated-orcid":false,"given":"Weidong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-0419","authenticated-orcid":false,"given":"Ya-Huei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4609-616X","authenticated-orcid":false,"given":"Sheng-Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3132-8557","authenticated-orcid":false,"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqiu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-5908","authenticated-orcid":false,"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-1327","authenticated-orcid":false,"given":"Zhaohui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-3502","authenticated-orcid":false,"given":"J. Jefferson P.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3581-754X","authenticated-orcid":false,"given":"Yun Lyna","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-939X","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian, H. et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 11, 41 (2021).","journal-title":"Blood Cancer J."},{"key":"1184_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/cancers10090340","volume":"10","author":"BU Mueller","year":"2018","unstructured":"Mueller, B. U., Seipel, K., Bacher, U. & Pabst, T. Autologous transplantation for older adults with AML. Cancers 10, 340 (2018).","journal-title":"Cancers"},{"key":"1184_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1517\/14728222.2013.733001","volume":"17","author":"S Thomas","year":"2013","unstructured":"Thomas, S. et al. Targeting the Bcl-2 family for cancer therapy. Expert Opin. Ther. Targets 17, 61\u201375 (2013).","journal-title":"Expert Opin. Ther. Targets"},{"key":"1184_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1182\/blood.2020006785","volume":"138","author":"AW Roberts","year":"2021","unstructured":"Roberts, A. W., Wei, A. H. & Huang, D. C. S. BCL2 and MCL1 inhibitors for hematologic malignancies. Blood 138, 1120\u20131136 (2021).","journal-title":"Blood"},{"key":"1184_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1158\/2159-8290.CD-21-1334","volume":"12","author":"J Montero","year":"2022","unstructured":"Montero, J. & Haq, R. Adapted to survive: targeting cancer cells with BH3 mimetics. Cancer Discov. 12, 1217\u20131232 (2022).","journal-title":"Cancer Discov."},{"key":"1184_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1182\/blood.2022016090","volume":"141","author":"DM Moujalled","year":"2023","unstructured":"Moujalled, D. M. et al. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia. Blood 141, 634\u2013644 (2023).","journal-title":"Blood"},{"key":"1184_CR7","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","volume":"1","author":"BM Stevens","year":"2020","unstructured":"Stevens, B. M. et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat. Cancer 1, 1176\u20131187 (2020).","journal-title":"Nat. Cancer"},{"key":"1184_CR8","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/2159-8290.CD-22-0601","volume":"13","author":"C Glytsou","year":"2023","unstructured":"Glytsou, C. et al. Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia. Cancer Discov. 13, 1656\u20131677 (2023).","journal-title":"Cancer Discov."},{"key":"1184_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","volume":"27","author":"CL Jones","year":"2020","unstructured":"Jones, C. L. et al. Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells. Cell Stem Cell 27, 748\u2013764 e744 (2020).","journal-title":"Cell Stem Cell"},{"key":"1184_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment. Cancer Discov. 9, 890\u2013909 (2019).","journal-title":"Cancer Discov."},{"key":"1184_CR11","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/2159-8290.CD-22-1297","volume":"13","author":"S Pei","year":"2023","unstructured":"Pei, S. et al. A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy. Cancer Discov. 13, 2032\u20132049 (2023).","journal-title":"Cancer Discov."},{"key":"1184_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1184_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","volume":"17","author":"Y Saito","year":"2015","unstructured":"Saito, Y., Chapple, R. H., Lin, A., Kitano, A. & Nakada, D. AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow. Cell Stem Cell 17, 585\u2013596 (2015).","journal-title":"Cell Stem Cell"},{"key":"1184_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.stem.2018.05.021","volume":"23","author":"S Pei","year":"2018","unstructured":"Pei, S. et al. AMPK\/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells. Cell Stem Cell 23, 86\u2013100 e106 (2018).","journal-title":"Cell Stem Cell"},{"key":"1184_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","volume":"36","author":"R Guieze","year":"2019","unstructured":"Guieze, R. et al. Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies. Cancer Cell 36, 369\u2013384 e313 (2019).","journal-title":"Cancer Cell"},{"key":"1184_CR16","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.3390\/cancers13235966","volume":"13","author":"N Legrand","year":"2021","unstructured":"Legrand, N. et al. AMP-activated protein kinase contributes to apoptosis induced by the Bcl-2 inhibitor venetoclax in acute myeloid leukemia. Cancers 13, 5966 (2021).","journal-title":"Cancers"},{"key":"1184_CR17","first-page":"1253","volume":"109","author":"RA Pan","year":"2024","unstructured":"Pan, R. A. et al. BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics. Haematologica 109, 1253\u20131258 (2024).","journal-title":"Haematologica"},{"key":"1184_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29304-6","volume":"13","author":"N Kawashima","year":"2022","unstructured":"Kawashima, N. et al. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells. Nat. Commun. 13, 1624 (2022).","journal-title":"Nat. Commun."},{"key":"1184_CR19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1182\/blood.2019001282","volume":"134","author":"X He","year":"2019","unstructured":"He, X. et al. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia. Blood 134, 548\u2013560 (2019).","journal-title":"Blood"},{"key":"1184_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s43018-024-00736-x","volume":"5","author":"H Dong","year":"2024","unstructured":"Dong, H. et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat. Cancer 5, 601\u2013624 (2024).","journal-title":"Nat. Cancer"},{"key":"1184_CR21","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1182\/bloodadvances.2021005859","volume":"6","author":"RR Schimmer","year":"2022","unstructured":"Schimmer, R. R. et al. TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms. Blood Adv. 6, 3201\u20133206 (2022).","journal-title":"Blood Adv."},{"key":"1184_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41419-021-04029-4","volume":"12","author":"DS Potter","year":"2021","unstructured":"Potter, D. S., Du, R., Bhola, P., Bueno, R. & Letai, A. Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer. Cell Death Dis. 12, 741 (2021).","journal-title":"Cell Death Dis."},{"key":"1184_CR23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cmet.2019.01.011","volume":"29","author":"KH Lin","year":"2019","unstructured":"Lin, K. H. et al. Systematic dissection of the metabolic-apoptotic interface in AML reveals heme biosynthesis to be a regulator of drug sensitivity. Cell Metab. 29, 1217\u20131231 e1217 (2019).","journal-title":"Cell Metab."},{"key":"1184_CR24","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1158\/2767-9764.CRC-23-0370","volume":"4","author":"M Poliakova Turan","year":"2024","unstructured":"Poliakova Turan, M. et al. E2F1-associated purine synthesis pathway is a major component of the MET-DNA damage response network. Cancer Res. Commun. 4, 1863\u20131880 (2024).","journal-title":"Cancer Res. Commun."},{"key":"1184_CR25","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1158\/2159-8290.CD-20-1065","volume":"11","author":"V Fresquet","year":"2021","unstructured":"Fresquet, V. et al. Endogenous retroelement activation by epigenetic therapy reverses the Warburg effect and elicits mitochondrial-mediated cancer cell death. Cancer Discov. 11, 1268\u20131285 (2021).","journal-title":"Cancer Discov."},{"key":"1184_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep14500","volume":"5","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. O-GlcNAcylation regulates ischemia-induced neuronal apoptosis through AKT signaling. Sci. Rep. 5, 14500 (2015).","journal-title":"Sci. Rep."},{"key":"1184_CR27","doi-asserted-by":"publisher","first-page":"e68667","DOI":"10.1371\/journal.pone.0068667","volume":"8","author":"L Daftuar","year":"2013","unstructured":"Daftuar, L., Zhu, Y., Jacq, X. & Prives, C. Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS ONE 8, e68667 (2013).","journal-title":"PLoS ONE"},{"key":"1184_CR28","doi-asserted-by":"publisher","first-page":"eadh1436","DOI":"10.1126\/sciadv.adh1436","volume":"9","author":"Y Nishida","year":"2023","unstructured":"Nishida, Y. et al. Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias. Sci. Adv. 9, eadh1436 (2023).","journal-title":"Sci. Adv."},{"key":"1184_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","volume":"9","author":"M Certo","year":"2006","unstructured":"Certo, M. et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9, 351\u2013365 (2006).","journal-title":"Cancer Cell"},{"key":"1184_CR30","doi-asserted-by":"publisher","first-page":"e26693","DOI":"10.7554\/eLife.26693","volume":"6","author":"HT Huang","year":"2017","unstructured":"Huang, H. T. et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. eLife 6, e26693 (2017).","journal-title":"eLife"},{"key":"1184_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cbpb.2007.01.013","volume":"147","author":"X Li","year":"2007","unstructured":"Li, X. et al. Comparative molecular characterization of ADSS1 and ADSS2 genes in pig (Sus scrofa). Comp. Biochem. Physiol. B 147, 271\u2013277 (2007).","journal-title":"Comp. Biochem. Physiol. B"},{"key":"1184_CR32","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","volume":"52","author":"MH G\u00edslason","year":"2024","unstructured":"G\u00edslason, M. H. et al. BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis. Nucleic Acids Res. 52, D1138\u2013d1142 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1184_CR33","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1182\/blood.2021015108","volume":"139","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade. Blood 139, 3752\u20133770 (2022).","journal-title":"Blood"},{"key":"1184_CR34","doi-asserted-by":"publisher","first-page":"e139929","DOI":"10.1172\/JCI139929","volume":"131","author":"F Huang","year":"2021","unstructured":"Huang, F. et al. Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer. J. Clin. Invest. 131, e139929 (2021).","journal-title":"J. Clin. Invest."},{"key":"1184_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41586-019-1367-0","volume":"571","author":"AS Nam","year":"2019","unstructured":"Nam, A. S. et al. Somatic mutations and cell identity linked by genotyping of transcriptomes. Nature 571, 355\u2013360 (2019).","journal-title":"Nature"},{"key":"1184_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood.2019003988","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo, C. D. et al. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. Blood 135, 791\u2013803 (2020).","journal-title":"Blood"},{"key":"1184_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.81","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon, S. M. Regulation and function of AMPK in physiology and diseases. Exp. Mol. Med. 48, e245 (2016).","journal-title":"Exp. Mol. Med."},{"key":"1184_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","volume":"18","author":"RG Jones","year":"2005","unstructured":"Jones, R. G. et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283\u2013293 (2005).","journal-title":"Mol. Cell"},{"key":"1184_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bmcl.2010.10.088","volume":"21","author":"N Tibrewal","year":"2011","unstructured":"Tibrewal, N. & Elliott, G. I. Evaluation of hadacidin analogues. Bioorg. Med. Chem. Lett. 21, 517\u2013519 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1184_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0014-5793(92)80465-S","volume":"303","author":"SM Powell","year":"1992","unstructured":"Powell, S. M., Zalkin, H. & Dixon, J. E. Cloning and characterization of the cDNA encoding human adenylosuccinate synthetase. FEBS Lett. 303, 4\u201310 (1992).","journal-title":"FEBS Lett."},{"key":"1184_CR41","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1158\/0008-5472.CAN-23-1006","volume":"83","author":"E Griessinger","year":"2023","unstructured":"Griessinger, E. et al. Oxidative phosphorylation fueled by fatty acid oxidation sensitizes leukemic stem cells to cold. Cancer Res. 83, 2461\u20132470 (2023).","journal-title":"Cancer Res."},{"key":"1184_CR42","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, 724\u2013740 e724 (2018).","journal-title":"Cancer Cell"},{"key":"1184_CR43","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.clnves.2025.100007","volume":"1","author":"S Hou","year":"2025","unstructured":"Hou, S., Liu, J. & Zhu, Y. Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia. Cell Investig. 1, 100007 (2025).","journal-title":"Cell Investig."},{"key":"1184_CR44","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.clnves.2025.100044","volume":"1","author":"C Jia","year":"2025","unstructured":"Jia, C., Liang, Z., Yao, X., Lin, Q. & Zhang, Y. CRISPR libraries: a powerful screening tool for function and mechanism study of cancer. Cell Investig. 1, 100044 (2025).","journal-title":"Cell Investig."},{"key":"1184_CR45","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1096\/fj.201903051R","volume":"34","author":"AP Seabright","year":"2020","unstructured":"Seabright, A. P. et al. AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent manner. FASEB J. 34, 6284\u20136301 (2020).","journal-title":"FASEB J."},{"key":"1184_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nature09571","volume":"468","author":"D Nakada","year":"2010","unstructured":"Nakada, D., Saunders, T. L. & Morrison, S. J. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653\u2013658 (2010).","journal-title":"Nature"},{"key":"1184_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110197","volume":"38","author":"A Grenier","year":"2022","unstructured":"Grenier, A. et al. AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia. Cell Rep. 38, 110197 (2022).","journal-title":"Cell Rep."},{"key":"1184_CR48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41419-023-06120-4","volume":"14","author":"F Sneyers","year":"2023","unstructured":"Sneyers, F. et al. Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing MCL-1-addicted cancer cells. Cell Death Dis. 14, 600 (2023).","journal-title":"Cell Death Dis."},{"key":"1184_CR49","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1158\/1078-0432.CCR-22-2729","volume":"29","author":"T Satta","year":"2023","unstructured":"Satta, T. et al. Dual mTORC1\/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax. Clin. Cancer Res. 29, 1332\u20131343 (2023).","journal-title":"Clin. Cancer Res."},{"key":"1184_CR50","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","volume":"31","author":"A Gonzalez","year":"2020","unstructured":"Gonzalez, A., Hall, M. N., Lin, S. C. & Hardie, D. G. AMPK and TOR: the yin and yang of cellular nutrient sensing and growth control. Cell Metab. 31, 472\u2013492 (2020).","journal-title":"Cell Metab."},{"key":"1184_CR51","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.celrep.2017.10.029","volume":"21","author":"G Hoxhaj","year":"2017","unstructured":"Hoxhaj, G. et al. The mTORC1 signaling network senses changes in cellular purine nucleotide levels. Cell Rep. 21, 1331\u20131346 (2017).","journal-title":"Cell Rep."},{"key":"1184_CR52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.20517\/cdr.2021.125","volume":"5","author":"F Ong","year":"2022","unstructured":"Ong, F., Kim, K. & Konopleva, M. Y. Venetoclax resistance: mechanistic insights and future strategies. Cancer Drug Resist. 5, 380\u2013400 (2022).","journal-title":"Cancer Drug Resist."},{"key":"1184_CR53","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1182\/blood.2020010167","volume":"137","author":"R Thijssen","year":"2021","unstructured":"Thijssen, R. et al. Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias. Blood 137, 2721\u20132735 (2021).","journal-title":"Blood"},{"key":"1184_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.stem.2018.07.018","volume":"23","author":"J Sun","year":"2018","unstructured":"Sun, J. et al. SIRT1 activation disrupts maintenance of myelodysplastic syndrome stem and progenitor cells by restoring TET2 function. Cell Stem Cell 23, 355\u2013369 e359 (2018).","journal-title":"Cell Stem Cell"},{"key":"1184_CR55","doi-asserted-by":"publisher","first-page":"eadk3127","DOI":"10.1126\/sciadv.adk3127","volume":"10","author":"AKN Chan","year":"2024","unstructured":"Chan, A. K. N. et al. Therapeutic targeting Tudor domains in leukemia via CRISPR-scan assisted drug discovery. Sci. Adv. 10, eadk3127 (2024).","journal-title":"Sci. Adv."},{"key":"1184_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41594-024-01211-y","volume":"31","author":"NM Mattson","year":"2024","unstructured":"Mattson, N. M. et al. A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens. Nat. Struct. Mol. Biol. 31, 465\u2013475 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1184_CR57","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","volume":"21","author":"L Li","year":"2012","unstructured":"Li, L. et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell 21, 266\u2013281 (2012).","journal-title":"Cancer Cell"},{"key":"1184_CR58","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ccell.2020.10.010","volume":"38","author":"S Bhatt","year":"2020","unstructured":"Bhatt, S. et al. Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia. Cancer Cell 38, 872\u2013890 e876 (2020).","journal-title":"Cancer Cell"},{"key":"1184_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccell.2019.11.003","volume":"37","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer. Cancer Cell 37, 37\u201354 e39 (2020).","journal-title":"Cancer Cell"},{"key":"1184_CR60","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.talanta.2017.11.054","volume":"179","author":"B Zhu","year":"2018","unstructured":"Zhu, B. et al. A simultaneously quantitative method to profiling twenty endogenous nucleosides and nucleotides in cancer cells using UHPLC-MS\/MS. Talanta 179, 615\u2013623 (2018).","journal-title":"Talanta"},{"key":"1184_CR61","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"1184_CR62","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"1184_CR63","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1021\/ja0100120","volume":"123","author":"M Mayer","year":"2001","unstructured":"Mayer, M. & Meyer, B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108\u20136117 (2001).","journal-title":"J. Am. Chem. Soc."},{"key":"1184_CR64","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100\u20132122 (2014).","journal-title":"Nat. Protoc."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01184-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01184-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01184-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:03:31Z","timestamp":1782482611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01184-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1038\/s43018-026-01184-5","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}